|
With the great success of first two meetings on Bioavailability and Bioequivalence, BIOBIO-2010 and BABE-2011; OMICS Group, the World Class Open Access Publisher and Scientific Events Organizer is hosting the 3rd World Congress on Bioavailability and Bioequivalence: Pharmaceutical R & D Summit during 26-28 March at Hyderabad, India
|
|
The main theme of BABE-2012 is "Novel approaches in Drug development by comparing Bioavailability and Bioequivalence studies".
|
| Web site URL: http://www.omicsonline.org/BABE2012 |
|
OMICS Group aims in making this BABE 2012 conference a perfect platform to share experiences through research talks and in bringing out solution to the problems at industry level by putting forward many thought provoking strategies.
|
|
BABE 2012 has an enhanced feature of B2B Partnering which provides an electronic communication among scientists, researchers, leading industry professionals, business development executives and corporate investors
|
| For B2B Networking please visit: http://www.omicsonline.org/BABE2012/b2b/registration.php |
|
100 renowned speakers from 25 countries confirmed their participation
|
|
BABE 2012 is supported by Agilent Technologies, AB SCIEX, Thermo Fisher Scientific (India) Pvt. Ltd, Quest Life Sciences (P) Ltd, Drug Monitoring Research Institute and Sci Technol Biosolutions. |
|
We welcome you to be a part of this exciting conference BABE 2012 as delegate/Speaker/Exhibitor/Sponsor to share your views in transferring and exchanging Ideas through global networking and aim at Accelerating Scientific Discoveries
|
| |
